Table 1A)
Baseline Characteristic All (n = 403) RF (n = 345) Cryo (n = 58) p value
Age - year 62.3 +/- 9.1 62.2 +/- 9.1 63.1 +/- 8.8 p = 0.46
Male sex - no (%) 321 (79.7) 274 (79.4) 47 (81.0) p = 0.91
Race - white 374 (92.8) 318 (92.2) 56 (96.6) p = 0.41
CHF 66 (16.4) 53 (15.4) 13(22.4) p = 0.25
HTN 237 (58.8) 202 (58.6) 35 (60.3) p = 0.91
Vascular Disease 39 (9.7) 31 (9.0) 8 (13.8) p = 0.37
Diabetes 43 (10.7) 36 (10.4) 7 (12.1) p = 0.89
Prior Stroke/TIA 34 (8.4) 28 (8.1) 6 (10.3) p = 0.61
CAD 49 (12.2) 42 (12.2) 7 (12.1) p = 1.0
CABG 8 (2.0) 8 (2.3) 0 (0) p = 0.61
CHA2DS2VASC 1.9 +/- 1.4 2.0 +/- 1.4 1.8 +/- 1.3 p = 0.45
Tobacco 159 (39.5) 133(38.6) 26 (44.8) p = 0.45
Hyperlipidemia 136 (3.4) 122 (35.4) 14 (24.1) p = 0.13
Mitral Valve Disease 25 (6.2) 21 (6.1) 4 (6.9) p = 0.77
Rheumatic Fever 3 (0.7) 3 (0.9) 0 (0) p = 1.0
Antiarrhythmic use prior 191 (47.4) 172 (49.9) 19 (32.8) p = 0.02
Beta Blocker 296 (73.4) 256 (74.2) 40 (69.0) p = 0.50
ACEi 113 (28.0) 98 (28.4) 15 (25.9) p = 0.81
ARB 100 (24.8) 90 (26.1) 10 (17.2) p = 0.20
Statin 131 (32.5) 108 (31.2) 23 (39.7) p = 0.27
Anticoagulation drug 387 (96.0) 335 (97.1) 52 (89.7) p = 0.02
Antiplatelet 17 (4.2) 15 (4.3) 2 (3.4) p = 1.0
BNP 252.7 +/- 327.6 218.8 +/- 285.8 407.1 +/- 448.8 p = 0.05
Table 1B)
Baseline Procedural Characteristics All (n = 403) RF (n = 345) Cryo (n = 58) p value
Total fluoroscopy time 14.1 +/- 10.6 13.9 +/- 11.1 15.6 +/- 7.4 p = 0.14
Total sheath time 140.2 +/- 61.4 146.4 +/- 63.2 103.4 +/- 29.6 p = 0.001
Total transseptal time 112.6 +/- 50.5 117.4 +/- 52.0 84.4 +/- 26.4 p = 0.001